{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:38:26Z","timestamp":1776789506847,"version":"3.51.2"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.urology.2007.06.1102","type":"journal-article","created":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T05:14:59Z","timestamp":1196486099000},"page":"743-747","source":"Crossref","is-referenced-by-count":48,"title":["Association of Extent and Aggressiveness of Inflammation with Serum PSA Levels and PSA Density in Asymptomatic Patients"],"prefix":"10.1016","volume":"70","author":[{"given":"Engin","family":"Kandirali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cetin","family":"Boran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdinc","family":"Serin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atilla","family":"Semercioz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Metin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2007.06.1102_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0022-5347(05)68543-6","article-title":"Prostate specific antigen: a decade of discovery\u2014What we have learned and where we are going","volume":"162","author":"Polascik","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.06.1102_bib2","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.urology.2004.07.017","article-title":"Prostatitis and prostate cancer: implications for prostate cancer screening","volume":"64","author":"Kawakami","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urology.2007.06.1102_bib3","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/1097-0142(19911001)68:7<1592::AID-CNCR2820680721>3.0.CO;2-M","article-title":"Prostate-specific antigen levels from completely sectioned, clinically benign, whole prostates","volume":"68","author":"Brawn","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2007.06.1102_bib4","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0022-5347(01)64957-7","article-title":"Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value","volume":"157","author":"Irani","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.06.1102_bib5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000020161","article-title":"Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density","volume":"37","author":"Schatteman","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2007.06.1102_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000071839","article-title":"Increased prostate-specific antigen in subclinical prostatitis: the role of the aggressiveness and extension of inflammation","volume":"71","author":"Yaman","year":"2003","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2007.06.1102_bib7","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.urology.2004.08.060","article-title":"Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study","volume":"64","author":"Simardi","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urology.2007.06.1102_bib8","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0090-4295(03)00688-5","article-title":"Effect of subclinical prostatic inflammation on serum PSA levels in men with clinically undetectable prostate cancer","volume":"62","author":"Kwak","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urology.2007.06.1102_bib9","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0022-5347(17)38508-7","article-title":"Determination of prostate volume by transrectal ultrasound","volume":"145","author":"Terris","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.06.1102_bib10","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<2162::AID-CNCR30>3.0.CO;2-R","article-title":"The National Cancer Data Base report on longitudinal observations on prostate cancer","volume":"15","author":"Mettlin","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2007.06.1102_bib11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-5347(01)64518-X","article-title":"Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate","volume":"158","author":"Fleshner","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.06.1102_bib12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1159\/000020190","article-title":"Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen","volume":"37","author":"Morote","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2007.06.1102_bib13","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0022-5347(01)63570-5","article-title":"The effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percentage of free serum prostate specific antigen levels in men without clinically detectable prostate cancer","volume":"159","author":"Ornstein","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.06.1102_bib14","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1097\/00005392-199805000-00050","article-title":"Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate","volume":"159","author":"Jung","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.06.1102_bib15","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.eururo.2004.08.003","article-title":"Effect of NIH-IV prostatitis on free and free-to-total PSA","volume":"46","author":"Stancik","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2007.06.1102_bib16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000051003","article-title":"Diagnostic accuracy of percent free prostate-specific antigen in prostatic pathology and its usefulness in monitoring prostatic cancer patients","volume":"67","author":"Minardi","year":"2001","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2007.06.1102_bib17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1159\/000020057","article-title":"Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia","volume":"36","author":"Scattoni","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2007.06.1102_bib18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jcb.20477","article-title":"Interleukin-6 regulation of prostate cancer cell growth","volume":"95","author":"Culig","year":"2005","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.urology.2007.06.1102_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.eururo.2007.03.054","article-title":"Obesity and prostate cancer: a role for adipokines","volume":"52","author":"Mistry","year":"2007","journal-title":"Eur Urol"},{"issue":"3 Pt 1","key":"10.1016\/j.urology.2007.06.1102_bib20","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00005392-200009010-00024","article-title":"Cytokine variations in patients with hormone treated prostate cancer","volume":"164","author":"Wise","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.06.1102_bib21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1442-2042.2006.01244.x","article-title":"Is chronic inflammatory change in the prostate the major cause of rising serum prostate-specific antigen in patients with clinical suspicion of prostate cancer?","volume":"13","author":"Chang","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2007.06.1102_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.epirev.a000783","article-title":"Medical history and etiology of prostate cancer","volume":"23","author":"Giovannucci","year":"2001","journal-title":"Epidemiol Rev"},{"issue":"2 Pt 2","key":"10.1016\/j.urology.2007.06.1102_bib23","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/01.ju.0000108131.43160.77","article-title":"Epidemiology of inflammation and prostate cancer","volume":"171","author":"Platz","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.06.1102_bib24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0090-4295(02)01637-0","article-title":"Epidemiologic association between prostatitis and prostate cancer","volume":"60","author":"Dennis","year":"2002","journal-title":"Urology"},{"issue":"2 Pt 2","key":"10.1016\/j.urology.2007.06.1102_bib25","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1097\/01.ju.0000108142.53241.47","article-title":"Inflammation as a target for prostate cancer chemoprevention: pathological and laboratory rationale","volume":"171","author":"Lucia","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.06.1102_bib26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00345-003-0335-2","article-title":"The role of cytokines in prostatitis","volume":"21","author":"Jang","year":"2003","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2007.06.1102_bib27","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.eururo.2006.12.011","article-title":"Is benign prostatic hyperplasia (BPH) an \u0131mmune \u0131nflammatory disease?","volume":"51","author":"Kramer","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2007.06.1102_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/pros.10238","article-title":"Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate","volume":"56","author":"Steiner","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2007.06.1102_bib29","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/pros.20381","article-title":"Three new serum markers for prostate cancer detection within a percent free PSA-based artificial neural network","volume":"66","author":"Stephan","year":"2006","journal-title":"Prostate"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429507017815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429507017815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T11:16:06Z","timestamp":1557054966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429507017815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0090429507017815"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2007.06.1102","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}